Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

Conclusions:
BCI had a strong prognostic effect on RFS in patients with early-stage breast cancer treated with tamoxifen alone or with tamoxifen and octreotide. BCI was prognostic in both LN− and LN+ patients. This retrospective study is an independent validation of the prognostic performance of BCI in a prospective trial.

Source: Breast Cancer Research - January 4, 2016 Category: Cancer & Oncology Authors: Dennis SgroiJudy-Anne ChapmanT. Badovinac-CrnjevicElizabeth ZarellaShemeica BinnsYi ZhangCatherine SchnabelMark ErlanderKathleen PritchardLei HanLois ShepherdPaul GossMichael Pollak Source Type: research